<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03498898</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-17-IM-0598-CTIL</org_study_id>
    <nct_id>NCT03498898</nct_id>
  </id_info>
  <brief_title>The Effect of Ongoing Beta-blockers Administration on Analgesic Requirements in the Immediate Perioperative Period.</brief_title>
  <official_title>The Effect of Ongoing Beta-blockers Administration on Analgesic Requirements in the Immediate Perioperative Period.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to discover if chronic use of Beta adrenergic receptor blockers
      affects pain sensation during and after an elective procedure of hip replacement. The study's
      population will be divided to two groups: Group A- chronic use of Beta adrenergic receptor
      blockers and Group B- no use of Beta adrenergic receptor blockers. Each patient will be
      anesthetized using the same anesthesia protocol with pain assessment done by the ANI device
      intra operatively and by NRS score postoperatively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effect of ongoing Beta adrenergic receptor blockers administration on perioperative and
      post-operative pain.

      Beta adrenergic receptor blockers are in common use for treatment of a variety of illnesses.
      Mostly ones that are connected to the cardiovascular system (such as congestive heart
      failure, angina pectoris and dysrhythmias) but also for treatment of some neurological
      disorders and more.

      Esmolol and Labetalol are frequently utilized during the perioperative period because of
      their beneficial effects in treating the acute hemodynamic response to surgical stress.
      However, clinical studies have confirmed that these adjuvant drugs can reduce postoperative
      opioid consumption and facilitate earlier extubation. In multiple studies, Esmolol was found
      effective reducing postoperative pain and the need for narcotic analgesics following surgery.
      A Meta-analysis published in 2015 in the Journal of Anesthesiology found that Esmolol caused
      a 32-50% reduction in the need for rescue analgesics and that propranolol decreased the need
      for rescue analgesics by 72%.

      The &quot;Analgesia Nociception Index&quot; (ANI; MetroDoloris Medical Systems, Lille, France), derived
      from an electrocardiogram (ECG) trace, has been proposed as a noninvasive guide to analgesia.
      The ANI monitor calculates heart rate variation with respiration, a response mediated
      primarily by changes in the parasympathetic nervous system (PNS) stimulation to the
      sinoatrial node of the heart . A painful stimulus will cause a relative decrease in
      parasympathetic tone and therefore result in a decrease in ANI scores. A score of 100
      indicates maximum parasympathetic tone and low nociceptive levels, while a score of zero
      indicates minimum parasympathetic tone and high nociceptive levels. ANI has been validated in
      a few studies. In a recently published clinical trial comparing ANI to other predictive
      modalities and to traditional clinical signs (heart rate and mean arterial pressure) ANI was
      found to have the highest sensitivity and specificity (P k -0.98) for detecting painful
      stimulations.

      The NRS for pain is a unidimensional measure of pain intensity in adults. The most commonly
      used is the 11-item NRS which is a segmented numeric version of the visual analog scale (VAS)
      in which a respondent selects a whole number (0 -10 integers) that best reflects the
      intensity of their pain where 0 is described as no pain and 10 is described as the worst pain
      imaginable. The NRS-11 is perhaps the most commonly used pain intensity rating tool with a
      highly correlated validity to the visual analogue scale (VAS). In addition High test-retest
      reliability has been observed in both literate and illiterate patients with rheumatoid
      arthritis (r 0.96 and 0.95, respectively).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">October 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fentanyl consumption during surgery.</measure>
    <time_frame>Intra operative (anaesthesia start until anaesthesia end).</time_frame>
    <description>Measuring the effect of chronic use of Beta adrenergic receptor blockers on the amount of analgesia (Fentanyl).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative Morphine consumption.</measure>
    <time_frame>Immediate post operative time (from admission to release from PACU).</time_frame>
    <description>Measuring the effect of chronic use of Beta adrenergic receptor blockers on the amount of analgesia (Morphine).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative non opioid analgesia consumption.</measure>
    <time_frame>Immediate post operative time (from admission to release from PACU).</time_frame>
    <description>Measuring the effect of chronic use of Beta adrenergic receptor blockers on the amount of non opioid analgesia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative pain (NRS score).</measure>
    <time_frame>15 minutes after admission to PACU.</time_frame>
    <description>Measuring the effect of chronic use of Beta adrenergic receptor blockers on NRS pain score.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nociceptive Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>American Society of Anesthesiologists (ASA) Score 2-3 with chronic use of Beta adrenergic receptor blockers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>American Society of Anesthesiologists (ASA) Score 2-3 with no chronic use of Beta adrenergic receptor blockers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Chronic use of Beta adrenergic receptor blocker</intervention_name>
    <description>Chronic use of Beta adrenergic receptor blocker</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Candidates for an elective hip replacement.

        Exclusion Criteria:

          -  Patients with no sinus rhythm.

          -  Patients with an internal cardiac device / cardiac pacemaker.

          -  The use of Anti muscarinic, alpha adrenergic receptor blockers or anti arhythmic
             medications.

          -  Chronic use of Opioids (defined as 20 mg or more of Oxycodone per day for a period of
             6 weeks or more).

          -  BMI&gt; 35.

          -  Sensitivity to one of the following drugs: Propofol, Fentanyl, Rocuronium, Isoflurane,
             Morphine, Acetaminophen, Ondansetron.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Idit Matot, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Idit Matot, MD, PhD</last_name>
    <phone>97236974758</phone>
    <email>iditm@tlvmc.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Miri Davidovich</last_name>
    <phone>97236974758</phone>
    <email>mirid@tlvmc.gov.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tel-Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>White PF. What are the advantages of non-opioid analgesic techniques in the management of acute and chronic pain? Expert Opin Pharmacother. 2017 Mar;18(4):329-333. doi: 10.1080/14656566.2017.1289176. Epub 2017 Feb 20.</citation>
    <PMID>28132576</PMID>
  </reference>
  <reference>
    <citation>Chia YY, Chan MH, Ko NH, Liu K. Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy. Br J Anaesth. 2004 Dec;93(6):799-805. Epub 2004 Sep 17.</citation>
    <PMID>15377583</PMID>
  </reference>
  <reference>
    <citation>Collard V, Mistraletti G, Taqi A, Asenjo JF, Feldman LS, Fried GM, Carli F. Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. Anesth Analg. 2007 Nov;105(5):1255-62, table of contents.</citation>
    <PMID>17959952</PMID>
  </reference>
  <reference>
    <citation>López-Álvarez S, Mayo-Moldes M, Zaballos M, Iglesias BG, Blanco-Dávila R. Esmolol versus ketamine-remifentanil combination for early postoperative analgesia after laparoscopic cholecystectomy: a randomized controlled trial. Can J Anaesth. 2012 May;59(5):442-8. doi: 10.1007/s12630-012-9684-x. Epub 2012 Mar 2.</citation>
    <PMID>22383085</PMID>
  </reference>
  <reference>
    <citation>Härkänen L, Halonen J, Selander T, Kokki H. Beta-adrenergic antagonists during general anesthesia reduced postoperative pain: a systematic review and a meta-analysis of randomized controlled trials. J Anesth. 2015 Dec;29(6):934-43. doi: 10.1007/s00540-015-2041-9. Epub 2015 Jul 10. Review.</citation>
    <PMID>26160590</PMID>
  </reference>
  <reference>
    <citation>Funcke S, Sauerlaender S, Pinnschmidt HO, Saugel B, Bremer K, Reuter DA, Nitzschke R. Validation of Innovative Techniques for Monitoring Nociception during General Anesthesia: A Clinical Study Using Tetanic and Intracutaneous Electrical Stimulation. Anesthesiology. 2017 Aug;127(2):272-283. doi: 10.1097/ALN.0000000000001670.</citation>
    <PMID>28489614</PMID>
  </reference>
  <reference>
    <citation>De Jonckheere J, Logier R, Jounwaz R, Vidal R, Jeanne M. From pain to stress evaluation using heart rate variability analysis: development of an evaluation platform. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:3852-5. doi: 10.1109/IEMBS.2010.5627661.</citation>
    <PMID>21097068</PMID>
  </reference>
  <reference>
    <citation>Logier R, Jeanne M, De Jonckheere J, Dassonneville A, Delecroix M, Tavernier B. PhysioDoloris: a monitoring device for analgesia / nociception balance evaluation using heart rate variability analysis. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:1194-7. doi: 10.1109/IEMBS.2010.5625971.</citation>
    <PMID>21095676</PMID>
  </reference>
  <reference>
    <citation>Upton HD, Ludbrook GL, Wing A, Sleigh JW. Intraoperative &quot;Analgesia Nociception Index&quot;-Guided Fentanyl Administration During Sevoflurane Anesthesia in Lumbar Discectomy and Laminectomy: A Randomized Clinical Trial. Anesth Analg. 2017 Jul;125(1):81-90. doi: 10.1213/ANE.0000000000001984.</citation>
    <PMID>28598927</PMID>
  </reference>
  <reference>
    <citation>Dundar N, Kus A, Gurkan Y, Toker K, Solak M. Analgesia nociception index (ani) monitoring in patients with thoracic paravertebral block: a randomized controlled study. J Clin Monit Comput. 2018 Jun;32(3):481-486. doi: 10.1007/s10877-017-0036-9. Epub 2017 Jun 19.</citation>
    <PMID>28631050</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, McFarland CA. Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain. 1993 Nov;55(2):195-203.</citation>
    <PMID>8309709</PMID>
  </reference>
  <reference>
    <citation>Andersson V, Bergman S, Henoch I, Wickström Ene K, Otterström-Rydberg E, Simonsson H, Ahlberg K. Pain and pain management in hospitalized patients before and after an intervention. Scand J Pain. 2017 Apr;15:22-29. doi: 10.1016/j.sjpain.2016.11.006. Epub 2016 Dec 9.</citation>
    <PMID>28850341</PMID>
  </reference>
  <reference>
    <citation>Gruenewald M, Ilies C, Herz J, Schoenherr T, Fudickar A, Höcker J, Bein B. Influence of nociceptive stimulation on analgesia nociception index (ANI) during propofol-remifentanil anaesthesia. Br J Anaesth. 2013 Jun;110(6):1024-30. doi: 10.1093/bja/aet019. Epub 2013 Mar 6.</citation>
    <PMID>23471754</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2018</study_first_submitted>
  <study_first_submitted_qc>April 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>April 8, 2018</last_update_submitted>
  <last_update_submitted_qc>April 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Beta adrenergic receptor blockers</keyword>
  <keyword>Analgesia nociceptive index</keyword>
  <keyword>Total hip replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nociceptive Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Adrenergic beta-Antagonists</mesh_term>
    <mesh_term>Adrenergic Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

